Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/1996
10/31/1996CA2219221A1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1
10/31/1996CA2219028A1 Rar.beta. selective retinoid compounds for inhibiting gene expression promoted by ap1 protein and their use in therapy
10/31/1996CA2218037A1 Novel collagen formulations
10/31/1996CA2217696A1 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy
10/30/1996EP0739898A2 Phosphonomonoester nucleic acids, methods for their preparation and their use
10/30/1996EP0739892A2 Chromone derivatives
10/30/1996EP0739887A1 Cyclohexane compounds, process for their preparation and pharmaceutical compositions containing them
10/30/1996EP0739354A1 Compositions and methods using unbound mpl receptor for stimulating platelet production
10/30/1996EP0739343A1 Water soluble onium salt of taxo-diterpenoid
10/30/1996EP0739338A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide
10/30/1996EP0739336A1 Gem-disubstituted azacyclic tachykinin antagonists
10/30/1996EP0739210A1 Methods and compositions for the treatment of a host with a cellular proliferative disease
10/30/1996EP0532595B1 The pharmacological use of certain cystine derivatives
10/30/1996EP0527852B1 Method and compositions for treating injury
10/30/1996EP0512071B1 Method and compositions for inhibiting angiogenesis
10/30/1996CN1134705A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
10/30/1996CN1134700A Novel taxoids, their preparation and pharmaceutical compositions containing them
10/30/1996CN1134696A Substituted 5-ring heterocycles, their preparation and their use
10/30/1996CN1134671A Compositions for prevention and treatment of viral-induced tumors
10/30/1996CN1134670A Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
10/30/1996CN1134460A HTFIIIA gent
10/30/1996CN1134423A Adhesion receptor antagonists
10/30/1996CN1134419A N-(3-Benzofuranyl) urea-derivatives
10/30/1996CN1134413A 4-Mercaptobenzoylguanidine derivatives
10/30/1996CN1134279A Use of sertraline to treat cancer patients
10/30/1996CN1033143C Radiopharmaceutical formulations, their method of administration and process of preparation
10/29/1996US5569786 Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins"
10/29/1996US5569759 Water soluble texaphyrin metal complex preparation
10/29/1996US5569720 Water soluble; antitumor agents
10/29/1996US5569665 Peptidyl derivatives and their use as metalloproteinases inhibitors
10/29/1996US5569658 Tricyclic derivatives
10/29/1996US5569647 Angiopeptin cyclopeptide compounds
10/29/1996US5569530 X-rays
10/29/1996US5569471 Medicine for the treatment of tumor
10/29/1996US5569454 Methods of treating infection using natural killer stimulatory factor
10/28/1996CA2174892A1 Cyclohexane compounds; process for preparing the same and pharmaceutical compositions containing them
10/24/1996WO1996033282A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/24/1996WO1996033280A1 An adenovirus helper-virus system
10/24/1996WO1996033268A1 Apopain
10/24/1996WO1996033211A1 Biologically active peptides and compositions, their use
10/24/1996WO1996033203A1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof
10/24/1996WO1996033198A1 Tumor protease activated prodrugs of phosphoramide mustard analogs
10/24/1996WO1996033176A1 Novel hydroxamic acid and amino-carboxylate compounds as metalloprotease and tnf inhibitors
10/24/1996WO1996033172A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
10/24/1996WO1996033166A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors
10/24/1996WO1996033165A1 Derivatives of succinamide and their use as metalloproteinase inhibitor
10/24/1996WO1996033161A1 Derivatives of succinamide and their use as metalloproteinase inhibitors
10/24/1996WO1996033159A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase
10/24/1996WO1996032968A1 Compounds for cancer imaging and therapy
10/24/1996WO1996032966A1 Arteriovenous and venous graft treatments: methods and compositions
10/24/1996WO1996032964A1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
10/24/1996WO1996032958A1 Method for treatment of pain
10/24/1996WO1996032937A1 Benzothiophenes with novel basic side chains
10/24/1996CA2218679A1 Apopain
10/24/1996CA2218618A1 Method for treatment of pain
10/24/1996CA2218610A1 An adenovirus helper-virus system
10/24/1996CA2218597A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase
10/24/1996CA2218380A1 Novel hydroxamic and carbocylic acids as metalloprotease inhibitors
10/24/1996CA2218345A1 Novel hydroxamic acid and amino-carboxylate compounds as metalloprotease and tnf inhibitors
10/24/1996CA2216871A1 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/24/1996CA2215902A1 Benzothiophenes with novel basic side chains
10/24/1996CA2215839A1 Compounds for cancer imaging and therapy
10/24/1996CA2215631A1 Arteriovenous and venous graft treatments: methods and compositions
10/24/1996CA2215264A1 Tumor protease activated prodrugs of phosphoramide mustard analogs
10/23/1996EP0738725A2 Benzothiophenes with novel basic side chains
10/23/1996EP0738328A1 Composition containing nucleic acids, preparation and uses
10/23/1996EP0738327A1 Host-vector system for use in gene therapy
10/23/1996EP0738280A1 Superactive vip antagonists
10/23/1996EP0738273A1 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
10/23/1996EP0738267A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
10/23/1996EP0738266A1 Taxane derivatives
10/23/1996EP0738265A1 Taxane derivatives
10/23/1996EP0738154A1 N-terminus modified analogs of lhrh
10/23/1996EP0738148A1 Self-assembled taxo-diperpenoid nanostructures
10/23/1996EP0738145A1 Pharmaceutical compositions
10/23/1996EP0738144A1 Phenylmethyl hexanamides, and the use thereof
10/23/1996EP0738143A1 Curcumin, analogues of curcumin and novel uses thereof
10/23/1996EP0738114A1 Food products for preventing development of diseases and process for preparing same
10/23/1996EP0654995B1 4-oxa-1-azabicyclo (3,2,0) heptan-7-one derivatives as antitumor agents
10/23/1996EP0643699B1 6-(2-hydroxyethylaminoalkyl)-5,11-dioxo-5,6-dihydro-11h- indeno[1,2-c]isoquinolines and their use as antineoplastic agents
10/23/1996EP0593491B1 Luteinizing hormone releasing hormone antagonist peptides
10/23/1996CN1134153A Matrix metalloprotease inhibitors
10/23/1996CN1134151A Pyrazine carboxamide derivs., their production and their use in medicaments
10/23/1996CN1134146A Benzoyl guanidines, their production and their use in medicaments
10/23/1996CN1134111A Method of using insulin-like growth factor binding proteins
10/23/1996CN1133886A Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them
10/23/1996CN1133725A Repellent analgesic ointment for cancer or tumor
10/22/1996US5567831 Non-steroidal sulfatase inhibitor compounds and their method of use
10/22/1996US5567828 For treatment of post-menopausal diseases, i.e., osteoporosis, cardiovascular disorders, cancer
10/22/1996US5567807 Using an anionic exchange resin
10/22/1996US5567765 Artificial blood, contrast agent, organ preservative
10/22/1996US5567738 Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-Naphthoquinone for the treatment of cancer
10/22/1996US5567734 Phenyl-substituted alkylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them
10/22/1996US5567712 Naphthyl compounds, intermediates, compositions and methods
10/22/1996US5567707 Acronycine analogues
10/22/1996US5567686 Method for protection against genotoxic mutagenesis
10/22/1996US5567417 Method for inhibiting angiogenesis using heparinase
10/22/1996CA2094974C Stable porfimer sodium compositions and methods for their manufacture
10/22/1996CA2066409C Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
10/22/1996CA1338671C Light-induced killing of carcinoma cells
1 ... 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 ... 2211